Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01
FDA recall notice · announced January 9, 2013 · Hospira
Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.
The product
Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01
Reason for recall
Presence of Particulates; may contain glass particles
Notes
Distribution: Nationwide
Lot/code information: Lot 100953A, Exp 01OCT2013; Lot 120803A Exp 01DEC2013
Quantity: 361,600/1-mL ampules
Status: Terminated
Products in this recall event:
- Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01 (D-106-2013)
Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.